Premium
Weight Loss Results in Increased Expression of Anti‐Inflammatory Protein CRISPLD2 in Mouse Adipose Tissue
Author(s) -
Jackson Robert M.,
Griesel Beth A.,
Short Kevin R.,
Sparling David,
Freeman Willard M.,
Olson Ann Louise
Publication year - 2019
Publication title -
obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.438
H-Index - 199
eISSN - 1930-739X
pISSN - 1930-7381
DOI - 10.1002/oby.22652
Subject(s) - adipose tissue , weight loss , medicine , endocrinology , adipokine , adipocyte , adiponectin , obesity , type 2 diabetes , metabolic syndrome , downregulation and upregulation , biology , diabetes mellitus , insulin resistance , gene , biochemistry
Objective Obesity is a major risk factor for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus, whereas weight loss is associated with improved health outcomes. It is therefore important to learn how adipose contraction during weight loss contributes to improved health. It was hypothesized that adipose tissue undergoing weight loss would have a unique transcriptomic profile, expressing specific genes that might improve health. Methods This study conducted an RNA‐sequencing analysis of the epididymal adipose tissue of mice fed either a high‐fat diet (HFD) or a regular rodent chow diet (RD) ad libitum for 10 weeks versus a cohort of mice fed HFD for the first 5 weeks before being swapped to an RD for the remainder of the study (swapped diet [SWAP]). Results The swapped diet resulted in weight loss, with a parallel improvement in insulin sensitivity. RNA sequencing revealed several transcriptomic signatures distinct to adipose tissue in SWAP mice, distinguished from both RD and HFD adipose tissue. The analysis found a unique upregulated mRNA that encodes a secreted lipopolysaccharide‐binding glycoprotein (CRISPLD2) in adipose tissue. Whereas cellular CRISPLD2 protein levels were unchanged, plasma CRIPSLD2 levels increased in SWAP mice following weight loss and could correlate with insulin sensitivity. Conclusions Taken together, these data demonstrate that CRISPLD2 is a circulating adipokine that may regulate adipocyte remodeling during weight loss.